Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8512)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 5, 2019 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rajapaksha IG, Angus PW, Herath CB. Current therapies and novel approaches for biliary diseases. World J Gastrointest Pathophysiol 2019; 10(1): 1-10 [PMID: 30622832 DOI: 10.4291/wjgp.v10.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i1/1.htm |
| Number | Citing Articles |
| 1 |
Asmaa M. ShamsEldeen, Bahjat Al‐Ani, Hasnaa A. Ebrahim, Laila Rashed, Amul M. Badr, Abeer Attia, Ayman M. Farag, Samaa S. Kamar, Mohamed A. Haidara, Suliman Al Humayed, Mohammed Ali Eshra. Resveratrol suppresses cholestasis‐induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1–Smad3–miR21 axis and profibrogenic and hepatic injury biomarkers. Clinical and Experimental Pharmacology and Physiology 2021; 48(10): 1402 doi: 10.1111/1440-1681.13546
|
| 2 |
Mariusz Bral, A. M. James Shapiro. Cell Biology and Translational Medicine, Volume 9. Advances in Experimental Medicine and Biology 2020; 1288: 13 doi: 10.1007/5584_2020_517
|
| 3 |
Soyeon An, Eungyeong Jang, Jang-Hoon Lee. Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A Review. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/8761435
|
| 4 |
Christos Tsagkaris, Stavros P Papadakos, Dimitrios V Moysidis, Andreas S Papazoglou, Alexandra Koutsogianni, Marios Papadakis. Hepatomusculoskeletal disorders: Coining a new term might improve the management of the musculoskeletal manifestations of chronic liver disease. World Journal of Gastrointestinal Pathophysiology 2022; 13(4): 124-127 doi: 10.4291/wjgp.v13.i4.124
Abstract(310) |
Core Tip(314) |
Full Article(HTML)(1108)
|
Full Article (PDF)-5761K(117)
|
Full Article (Word)-105K(77)
|
Audio-1566K(7)
|
Peer-Review Report-249K(44)
|
Answering Reviewers-113K(43)
|
Times Cited (0)
|
Total Visits (4114)
|
Open
|
| 5 |
Abeer Mahmoud Badr, Mohamed Farid, Ahmed Abdel Aziz Biomy, Ayman Saber Mohamed, Noha Ahmed Mahana, Sohair Ramadan Fahmy. Protective effect of Toxocara vitulorum extract against alpha-naphthylisothiocyanate-induced cholangitis in rat. The Journal of Basic and Applied Zoology 2020; 81(1) doi: 10.1186/s41936-020-00197-5
|
| 6 |
Lindsey Kennedy, Vik Meadows, Jennifer Demieville, Laura Hargrove, Shohaib Virani, Shannon Glaser, Tianhao Zhou, Evan Rinehart, Victoria Jaeger, Konstantina Kyritsi, Linh Pham, Gianfranco Alpini, Heather Francis. Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling. Laboratory Investigation 2020; 100(6): 837 doi: 10.1038/s41374-020-0405-8
|
| 7 |
Indu G. Rajapaksha, Lakmie S. Gunarathne, Khashayar Asadi, Ross Laybutt, Sof Andrikopoulous, Ian E. Alexander, Mathew J. Watt, Peter W. Angus, Chandana B. Herath. Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. Hepatology Communications 2022; 6(5): 1056 doi: 10.1002/hep4.1884
|
| 8 |
Halyna Kuznietsova, Iryna Byelinska, Natalia Dziubenko, Oksana Lynchak, Demyd Milokhov, Olga Khilya, Nataliya Finiuk, Olga Klyuchivska, Rostyslav Stoika, Volodymyr Rybalchenko. Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione. Molecular and Cellular Biochemistry 2021; 476(8): 3021 doi: 10.1007/s11010-021-04144-y
|
| 9 |
Ala Mohagheghzadeh, Parmis Badr, Abdolali Mohagheghzadeh, Shiva Hemmati. Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties. Pharmaceuticals 2023; 16(6): 887 doi: 10.3390/ph16060887
|
| 10 |
Indu G. Rajapaksha, Lakmie S. Gunarathne, Peter W. Angus, Chandana B. Herath. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. Journal of Clinical Medicine 2021; 10(4): 702 doi: 10.3390/jcm10040702
|
| 11 |
Javier Martínez-García, Angie Molina, Gloria González-Aseguinolaza, Nicholas D. Weber, Cristian Smerdou. Gene Therapy for Acquired and Genetic Cholestasis. Biomedicines 2022; 10(6): 1238 doi: 10.3390/biomedicines10061238
|
| 12 |
Huiping Zhou, Jasmohan S. Bajaj, Grace L. Guo. Altered gut-liver axis in liver diseases. Liver Research 2019; 3(1): 1 doi: 10.1016/j.livres.2019.01.005
|
| 13 |
Vik Meadows, Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Fanyin Meng, Shohaib Virani, Evan Reinhart, Konstantina Kyritsi, Pietro Invernizzi, Zhihong Yang, Nan Wu, Suthat Liangpunsakul, Gianfranco Alpini, Heather Francis. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2−/− mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(12): 165557 doi: 10.1016/j.bbadis.2019.165557
|
| 14 |
Indu Rajapaksha. Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches. Livers 2022; 2(4): 372 doi: 10.3390/livers2040028
|
| 15 |
Massimiliano Cadamuro, Noemi Girardi, Gregory J. Gores, Mario Strazzabosco, Luca Fabris. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00115
|